Last updated on November 2017

Harmacodynamic equivalence study of ramipril 10 mg and atorvastatin 40 mg administered as a Cardiovascular Fixed Dose Combination Pill AAR as compared to monotherapy with the reference products Altace 10 mg and Lipitor 40 mg


Brief description of study

Harmacodynamic equivalence study of ramipril 10 mg and atorvastatin 40 mg administered as a Cardiovascular Fixed Dose Combination Pill AAR as compared to monotherapy with the reference products Altace 10 mg and Lipitor 40 mg

Detailed Study Description

Receive Ramipril and Atorvastatin or Altace and Lipitor for the treatment of High Blood Pressure

Clinical Study Identifier: TX9192

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Herenia Sanchez-Lacayo, CRC

Clinical Research of South Florida
Coral Gables, FL USA
  Connect »